Geriatric Medicines Market Types, Structure, Growth Volume & Applications To 2022-2030

The global geriatric medicine market for the historical period 2017–2018 and forecast period 2019–2027, rise in chronic diseases, increase in governments and NGOs supports for elderly and technological advancement for medication assistance are projected to drive the global geriatric medicine market during the forecast period

Get the sample copy of report@ https://qyresearchmedical.com/sample/111884

According to the report, the global geriatric medicine market was valued at US$ 672.0 Bn in 2018 and is anticipated to expand at a CAGR of 6.9% from 2019 to 2027

Increase in global geriatric population and Surge in Programs by Governments and NGOs to support Elderly Patients: Key Drivers

Rise in geriatric population has led to an increase in the incidence and prevalence of chronic diseases. According to the World Health Organization (WHO), people over the age of 65 form the fastest-growing population segment globally. The proportion of the world’s population over 60 years is expected to double from about 11% to 22% between 2000 and 2050.

Stroke is a leading cause of death in the U.S. According to the Centers for Disease Control and Prevention (CDC), stroke claims one fatality every 40 seconds in the U.S. and about 795,000 people become victims of stroke (85% acute ischemic) each year. About 610,000 of these are first or new strokes, and 185,000 are recurrent strokes.

The global geriatric medicines market is expanding at a significant growth rate due to increasing government support toward old people for their health, safety, and nursing care. The Federal Long Term Care Insurance Program in the U.S. is a favorable policy for the elderly people, which covers almost all the medical care/cost of people in the U.S. Likewise, the Long-Term Care Ombudsman Program provides nursing homes, residential care facilities, and assisted living facilities for elderly people in the U.S.

Technological Advancement for Medication Assistance Boost Market Growth

The elderly are presently able to manage their multiple prescription drugs problem owing to recent advances in technology. There are pill boxes with alarms that enable seniors to know what exact pill needs to be taken and when. Several companies are developing and selling smart pill bottles.

View full report@ https://qyresearchmedical.com/report/geriatric-medicines-market-therapeutic-category-analgesic-antihypertensive-statins-antidiabetic-proton-pump-inhibitor-anticoagulant-antipsychotic-and-antidepressant-condition-cardiovascular-arthritis-d-019-2030/111884

These pill bottles allow connecting their medications to doctors and pharmacies for data on how often patients are taking their medication. They also alert (like a text message or phone call) the elderly about the appropriate time to take their medication, in case they forget. Therefore, technological advancement in medical assistance is likely to drive geriatric medicine market globally

Side Effects in Elderly to Hamper Market

Elderly people are more sensitive to frequently used drugs such as benzodiazepines, NSAIDs, and opioids. High chances of adverse drug reaction (ADR) and overdose in the elderly can lead to uptake of other form of therapies (herbal medicines, Unani, physiotherapy etc.), which in turn is projected to hamper the geriatric medicines market

Global Geriatric medicine Market: Competitive Landscape

This report profiles major players in the global geriatric medicine market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global geriatric medicine market is highly fragmented, with the presence of a number of international as well as regional players

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111884/2900

Leading players operating in the global geriatric medicine market are

  • Pfizer, Inc.
  • Merck & Co., Inc.
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Sanofi S.A.
  • GlaxoSmithKline plc Eli Lilly and Company
  • Abbott Laboratories
  • Boehringer Ingelheim GmbH

Key Questions Answered in Global Geriatric Medicine Market Report

  • What is the scope of growth of product companies in the global geriatric medicine market?
  • What will be the Y-o-Y growth of the global geriatric medicine market between 2019 and 2027?
  • What is the influence of changing trends in the global geriatric medicine market?
  • Will North America continue to be the most profitable market for geriatric medicine providers?
  • Which factors are anticipated to hamper the growth of the global geriatric medicine market during the forecast period?
  • Which are the leading companies in the global geriatric medicine market?

Global Geriatric Medicine Market – Segmentation

Therapeutic Category

  • Analgesic
  • Antihypertensive
  • Statins
  • Antidiabetic
  • Proton Pump Inhibitor
  • Anticoagulant
  • Antipsychotic and Antidepressant
  • Others

Condition

  • Cardiovascular
  • Arthritis
  • Diabetes
  • Neurological
  • Cancer
  • Osteoporosis
  • Respiratory
  • Others

Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Geriatric Medicine Market

4. Market Overview

4.1. Introduction

4.1.1.  Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Geriatric Medicine Market Analysis and Forecast, 2017–2030

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Regulatory Scenario, by Region/Globally

5.2. Pipeline Analysis

5.3. Mergers & Acquisitions

6. Global Geriatric Medicine Market Analysis and Forecast, by Therapeutic Category

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Geriatric Medicine Market Value Forecast, by Therapeutic Category, 2017–2030

6.2.1. Analgesic

6.2.2. Antihypertensive

6.2.3. Statins

6.2.4. Antidiabetic

6.2.5. Proton Pump Inhibitor

6.2.6. Anticoagulant

6.2.7. Antipsychotic and Antidepressant

6.2.8. Others

6.3. Global Geriatric Medicine Market Attractiveness, by Therapeutic Category

7. Global Geriatric Medicine Market Analysis and Forecast, by Condition

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Global Geriatric Medicine Market Value Forecast, by Condition, 2017–2030

7.2.1. Cardiovascular

7.2.2. Arthritis

7.2.3. Diabetes

7.2.4. Neurological

7.2.5. Cancer

7.2.6. Osteoporosis

7.2.7. Respiratory

7.2.8. Others

7.3. Global Geriatric Medicine Market Attractiveness, by Condition

8. Global Geriatric Medicine Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition

8.1.1. Key Findings / Developments

8.2. Global Geriatric Medicine Market Value Forecast, by Distribution Channel, 2017–2030

8.2.1. Hospital Pharmacies

8.2.2. Retail Pharmacies

8.2.3. Online Pharmacies

8.3. Global Geriatric Medicine Market Attractiveness, by Distribution Channel

9. Global Geriatric Medicine Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Global Geriatric Medicine Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Geriatric Medicine Market Attractiveness, by Region

10. North America Geriatric Medicine Market Analysis and Forecast

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111884/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi